Clinical Trial Update: Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A [Phase 4]

View source ↗

Summary

This is a Phase 4 safety study of Alphanate in previously treated patients with severe Hemophilia A. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Alphanate (antihemophilic factor VIII concentrate)

Snippet

Sponsor: Grifols Biologicals, LLC | Conditions: Severe Hemophilia A | Phase 4 | Status: COMPLETED | Results posted: 2022-06-09